The Latest Cardiac and Vascular News
Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines superior catheter design with the latest dual clot detection innovation ALAMEDA, Calif., Jan. 10, 2023 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the U.S. Food […]
Pivotal study to evaluate Embrace™ Hydrogel Embolic System for the embolization of arterial bleeds in the peripheral vasculature BEDFORD, Mass., Jan. 10, 2023 /PRNewswire/ — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the enrollment of the first patient in the HALT Study1 for the treatment of peripheral […]
System includes mechanical and aspiration thrombectomy devices to treat peripheral vascular disease ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that Innova Vascular, Inc. (Innova) has submitted a […]
SANTA CLARA, Calif., Dec. 14, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company’s QuantaFlo® PAD test under real-world conditions, illustrating the benefits […]
Biomaterial catheters help avoid common vascular access complications, delivering improved patient outcomes and a lower cost of care BILLERICA, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI) today announced that Riverside Medical Center, located just outside the Chicago area, was the first in the nation to use its […]
Head-to-head observational analysis showed XARELTO® as effective in treating cancer-associated thromboembolism (CAT) as apixaban Venous thromboembolism (VTE) is the second-leading cause of death in patients with cancer1 TITUSVILLE, N.J., Dec. 9, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing […]
The AFX2 Endovascular AAA System integrates anatomical fixation with an advanced delivery system to facilitate treatment of patients with abdominal aortic aneurysm (AAA). IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company, dedicated to improving patients’ lives with innovative interventional treatments for vascular disease, today announced that it […]
MINNEAPOLIS, Dec. 6, 2022 /PRNewswire/ — VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced data presented at the VEITH Symposium, Nov. 15-19th, New York, New York. Overall, the data presented demonstrated that FLEX Vessel […]
TAMPA, Fla., Dec. 2, 2022 /PRNewswire/ — VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. hosted a lunch symposium titled ‘Sirolimus Coated Balloon in PAD Treatment: Choice of The Future’ which explored the utility of Sirolimus Coated Balloon treatment […]
Contact: Beth Bales Senior Communications Manager, SVS (312) 334-2316 ROSEMONT, ILL. (Dec. 1, 2022) – The Society for Vascular Surgery (SVS) has published an update to the SVS/American Venous Forum 2011 clinical practice guideline (CPG) on the care of patients with varicose veins. This guideline update was developed in collaboration […]
